MX2010005136A - Prevencion y tratamiento de infecciones secundarias tras una infeccion viral. - Google Patents

Prevencion y tratamiento de infecciones secundarias tras una infeccion viral.

Info

Publication number
MX2010005136A
MX2010005136A MX2010005136A MX2010005136A MX2010005136A MX 2010005136 A MX2010005136 A MX 2010005136A MX 2010005136 A MX2010005136 A MX 2010005136A MX 2010005136 A MX2010005136 A MX 2010005136A MX 2010005136 A MX2010005136 A MX 2010005136A
Authority
MX
Mexico
Prior art keywords
prevention
secondary infections
viral infection
treatment
following viral
Prior art date
Application number
MX2010005136A
Other languages
English (en)
Inventor
Marie-Claire Fichot
Norbert Sprenger
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39102986&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2010005136(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2010005136A publication Critical patent/MX2010005136A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Abstract

Esta invención se refiere a una composición nutricional sintética adecuada para utilizarse en la prevención de infecciones secundarias que resultan de una infección viral caracterizada por una actividad sialidasa que comprende un oligosacárido sialilado y N-acetil-lactosamina y/o un oligosacárido que contiene N-acetil-lactosamina. La invención además se extiende al uso de una composición en la prevención de infecciones secundarias tales como la otitis media.
MX2010005136A 2007-11-08 2008-11-05 Prevencion y tratamiento de infecciones secundarias tras una infeccion viral. MX2010005136A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07120259A EP2060257A1 (en) 2007-11-08 2007-11-08 Prevention and treatment of secondary infections following viral infection
PCT/EP2008/064991 WO2009059996A1 (en) 2007-11-08 2008-11-05 Prevention and treatment of secondary infections following viral infection

Publications (1)

Publication Number Publication Date
MX2010005136A true MX2010005136A (es) 2010-06-02

Family

ID=39102986

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010005136A MX2010005136A (es) 2007-11-08 2008-11-05 Prevencion y tratamiento de infecciones secundarias tras una infeccion viral.

Country Status (14)

Country Link
US (2) US20100233129A1 (es)
EP (2) EP2060257A1 (es)
CN (1) CN101909615A (es)
BR (1) BRPI0820183A2 (es)
CA (1) CA2704977A1 (es)
ES (1) ES2666678T3 (es)
MX (1) MX2010005136A (es)
MY (1) MY157860A (es)
PT (1) PT2217230T (es)
RU (1) RU2481844C2 (es)
SG (1) SG185339A1 (es)
TR (1) TR201807494T4 (es)
TW (1) TW200936147A (es)
WO (1) WO2009059996A1 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8961953B2 (en) * 2008-03-14 2015-02-24 Nestec S.A. Synbiotic mixture
UA110325C2 (en) 2009-07-03 2015-12-25 Australian Biomedical Company Pty Ltd Medicinal carbohydrates for treating respiratory conditions
CN102858191A (zh) * 2010-04-27 2013-01-02 N.V.努特里奇亚 6’-唾液酸化乳糖在婴儿和幼儿营养物中的用途
EP2465509A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating acute respiratory tract infections
CN103402376A (zh) 2010-12-31 2013-11-20 雅培制药有限公司 促进有益细菌生长的中性人乳寡糖
SG191395A1 (en) 2010-12-31 2013-08-30 Abbott Lab Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
SG10202110501RA (en) * 2010-12-31 2021-11-29 Abbott Lab Methods For Decreasing The Incidence Of Necrotizing Enterocolitis In Infants, Toddlers, Or Children Using Human Milk Oligosaccharides
EP2658548B1 (en) * 2010-12-31 2018-02-21 Abbott Laboratories Human milk oligosaccharides for modulating inflammation
MX352040B (es) 2010-12-31 2017-11-07 Abbott Lab Formulaciones nutricionales que incluyen los oligosacaridos de leche humana y los acidos grasos poliinsaturados de cadena larga y usos de las mismas.
WO2012092155A1 (en) * 2010-12-31 2012-07-05 Abbott Laboratories Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
NZ613180A (en) * 2010-12-31 2015-02-27 Abbott Lab Methods of using human milk oligosaccharides for improving airway respiratory health
MY180910A (en) 2010-12-31 2020-12-11 Abbott Lab Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
WO2012106662A2 (en) * 2011-02-04 2012-08-09 The Regents Of The University Of California New agents to treat/prevent amoebiasis
MY161034A (en) * 2011-02-10 2017-04-14 Nestec Sa Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk
RU2748839C2 (ru) 2011-06-20 2021-05-31 Х.Дж. Хайнц Компани Брэндс Ллк Композиции, способы и наборы для стимулирования мукозальной иммунной системы
ES2657744T3 (es) 2011-07-22 2018-03-06 Abbott Laboratories Galactoligosacáridos para prevenir lesiones y/o promover la curación del tracto gastrointestinal
US10639319B2 (en) 2011-08-29 2020-05-05 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
BR112014008425A2 (pt) * 2011-10-18 2017-04-11 Nestec Sa composição para o uso na promoção de angiogênese intestinal e de absorção de nutriente e de tolerância a alimentação enteral e/ou na prevenção e/ou no tratamento de inflamação intestinal e/ou na recuperação após a lesão e a cirurgia intestinal
EP2606897A1 (en) * 2011-12-22 2013-06-26 Laboratorios Del. Dr. Esteve, S.A. Methods and compositions for the treatment of diseases caused by enveloped viruses
WO2014100696A1 (en) * 2012-12-20 2014-06-26 Abbott Laboratories Nutritional formulations using human milk oligosaccharides for modulating inflammation
WO2016035043A1 (en) * 2014-09-04 2016-03-10 SMITH, Jerome Shelsley Probiotic composition
AU2016227595B2 (en) 2015-03-05 2020-08-27 Société des Produits Nestlé S.A. Compositions for use in the prevention or treatment of otitis or bronchitis in infants or young children
WO2016145628A1 (en) * 2015-03-18 2016-09-22 Nestec S.A. Composition comprising siallyllactose for use in enhancing learning skills and memory function
US10588917B2 (en) 2015-03-31 2020-03-17 Glycom A/S Mixtures of human milk oligosaccharides comprising 3 ′-O-sialyllactose
ES2760351T3 (es) * 2015-08-04 2020-05-13 Suedzucker Ag Utilización profiláctica de inulina contra la sinusitis
CN108541221B (zh) 2015-12-15 2023-02-28 格礼卡姆股份公司 Hmo的混合物
AU2017224113B2 (en) * 2016-02-25 2022-04-21 Applied Biological Laboratories, Inc. Compositions and methods for protecting against airborne pathogens and irritants
EP3498282A1 (en) 2017-12-12 2019-06-19 Rheinische Friedrich-Wilhelms-Universität Bonn 6'-sialyllactose for use in the treatment of hearing loss

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180674A (en) * 1990-04-16 1993-01-19 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
US6045854A (en) * 1997-03-31 2000-04-04 Abbott Laboraties Nutritional formulations containing oligosaccharides
CA2248971A1 (en) * 1997-10-31 1999-04-30 Kyowa Hakko Kogyo Co., Ltd. .beta.1, 3-n-acetylglucosaminyltransferase, dna encoding it and its use
SE9904581D0 (sv) 1999-12-15 1999-12-15 A & Science Invest Ab A novel helicobacter pylori-binding substance and use thereof
FI20001477A (fi) * 2000-06-21 2001-12-22 Carbion Oy Influenssavirusta sitova aine ja sen käyttö
FI20010118A (fi) 2001-01-19 2002-07-20 Carbion Oy Uudet helicobacter pylori reseptorit ja niiden käyttö
FI114895B (fi) * 2001-05-14 2005-01-31 Suomen Rehu Oy Ravinnon lisäaine
AU2002352531A1 (en) * 2001-06-29 2003-03-03 Carbion Oy Use of at least one glycoinhibitor substance
DE10147100A1 (de) * 2001-09-25 2003-04-17 Numico Res B V Antiinfektive Kohlenhydrate
AU2003282494A1 (en) * 2002-10-11 2004-05-04 Wyeth Nutritional formulations containing synbiotic substances
EP2497478A3 (en) * 2003-12-05 2012-11-07 Children's Hospital Medical Center Oligosaccaride compositions and use thereof in the treatment of infection
ES1056525Y (es) 2004-01-13 2004-07-16 Perez Alfredo Pineiro Halador de tres rodillos para redes y aparejos de pesca.
US7862808B2 (en) 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
EP1988786B2 (en) * 2006-02-10 2019-10-09 Société des Produits Nestlé S.A. Oligosaccharide mixture
EP1993576B1 (en) 2006-03-07 2015-10-21 Nestec S.A. Synbiotic mixture

Also Published As

Publication number Publication date
BRPI0820183A2 (pt) 2015-06-23
WO2009059996A1 (en) 2009-05-14
CN101909615A (zh) 2010-12-08
PT2217230T (pt) 2018-04-24
EP2060257A1 (en) 2009-05-20
SG185339A1 (en) 2012-11-29
RU2010123174A (ru) 2011-12-20
TW200936147A (en) 2009-09-01
US20130131014A1 (en) 2013-05-23
EP2217230A1 (en) 2010-08-18
CA2704977A1 (en) 2009-05-14
ES2666678T3 (es) 2018-05-07
MY157860A (en) 2016-07-29
TR201807494T4 (tr) 2018-06-21
AU2008324205A1 (en) 2009-05-14
RU2481844C2 (ru) 2013-05-20
US20100233129A1 (en) 2010-09-16
EP2217230B1 (en) 2018-02-28

Similar Documents

Publication Publication Date Title
MX2010005136A (es) Prevencion y tratamiento de infecciones secundarias tras una infeccion viral.
GEP20135964B (en) Inhibitors of beta-secretase
IN2012DN01233A (es)
GEP20146125B (en) Aminopyrimidines as syk inhibitors
MX2010001733A (es) Compustos de imidazo[1,2-a]pirazina para tratamiento de infecciones virales tales como hepatitis.
WO2008115281A3 (en) Compounds for treating viral infections
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
MX346665B (es) Composiciones pesticidas y procedimientos relacionados con estas.
WO2009026179A3 (en) Antiinfective proanthocyanidin compounds and methods of use thereof
AU2010246102A8 (en) Pesticidal compositions
GEP20156370B (en) Fluoro-pyridinone derivatives useful as antibacterial agents
MX348481B (es) Productos quimicos, composiciones y metodos para tratamiento y prevencion de infecciones de virus orthopox y enfermedades asociadas.
GB0625648D0 (en) Compounds
HK1133787A1 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
MX2012007098A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
UA104885C2 (uk) Ізотіазолілоксифеніламідини та їх застосування як фунгіцидів
NZ602544A (en) Crystalline forms of a macrolide, and uses therefor
MX2012007161A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
TW200630367A (en) Substituted adenines and the uses thereof
MX2012004780A (es) Inhibidores de akt.
MX2009008495A (es) Novedosos analogos de nucleosidos para el tratamiento de infecciones virales.
WO2007120374A3 (en) Anti-arenaviral compounds
NZ596628A (en) Ketolide compounds having antimicrobial activity
MX2011012643A (es) 2,4-diaminopiridinas para el tratamiento de enfermedades caracterizadas por la proliferacion celular excesiva o anormal.

Legal Events

Date Code Title Description
FG Grant or registration